Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H19NO3.ClH |
Molecular Weight | 261.745 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)NC[C@H](O)COC1=CC=C(O)C=C1
InChI
InChIKey=WDXYIFGETVGLBZ-MERQFXBCSA-N
InChI=1S/C12H19NO3.ClH/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12;/h3-6,9,11,13-15H,7-8H2,1-2H3;1H/t11-;/m0./s1
Molecular Formula | C12H19NO3 |
Molecular Weight | 225.2842 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation. | 1984 Jun |
|
Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. | 1989 Mar |
|
Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists. | 1999 Nov |
|
beta1 to beta3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct beta-adrenoceptor subtype mediation of proliferation and differentiation. | 1999 Sep |
|
[Monoclonal gammopathy of undetermined significance (MGUS): establishment of premyeloma concept]. | 2002 Jul |
|
Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. | 2003 Aug |
|
Ion-selective electrode for the determination of prenalterol. | 2003 May 1 |
|
Regulation of postburn ischemia by alpha- and beta-adrenoceptor subtypes. | 2005 Mar |
|
Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats. | 2005 Nov |
|
beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. | 2007 Sep 10 |
|
Towards a thermodynamic definition of efficacy in partial agonism: The thermodynamics of efficacy and ligand proton transfer in a G protein-coupled receptor of the rhodopsin class. | 2010 Nov 15 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7270401
The eight patients were given prenalterol (PNL) orally, 30 to 200 mg/day, versus placebo for 6 days
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:44:11 GMT 2023
by
admin
on
Sat Dec 16 05:44:11 GMT 2023
|
Record UNII |
U6VH18LCQ8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1160714
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
DTXSID40210161
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
61260-05-7
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
100000085077
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
SUB04029MIG
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
43590
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
U6VH18LCQ8
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
262-676-5
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | |||
|
m9123
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
C170344
Created by
admin on Sat Dec 16 05:44:11 GMT 2023 , Edited by admin on Sat Dec 16 05:44:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |